FindMyKOL
Clinical trialNCT06342284RecruitingObservational

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

NCT06342284 is an observational study sponsored by The New York Proton Center. As of 21 Nov 2026, it is recruiting participants. It studies Thoracic Cancer. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 22 Mar 2024 and a primary completion date of 31 Mar 2028. One of its registered investigators has a FindMyKOL profile.

SponsorThe New York Proton Center →Enrollment40Thoracic Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT06342284
FieldValue
Registry IDNCT06342284
StatusRecruiting
Study typeObservational study
Lead sponsorThe New York Proton Center
Enrollment40
Registered sites1
Countries1
ConditionsThoracic Cancer
Start22 Mar 2024
Primary completion31 Mar 2028
Study completion21 Mar 2031
Last update posted13 Apr 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site, 1 recruiting
  • New York Proton Center

    New York

    Alexandra Hanlon, PhDAnnemarie Shepherd, MDCharles Simone, MDNitin Ohri, MD →Stanislav Lazarev, MD
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 site, 1 recruitingNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT06342284

Each answer restates registry values shown on this page.

What is NCT06342284?

NCT06342284 is an observational study sponsored by The New York Proton Center. It studies Thoracic Cancer.

Is NCT06342284 recruiting?

As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.

Who leads NCT06342284?

The registry names Nitin Ohri, MD (principal investigator, Montefiore Medical Center) as the overall official.

Where does NCT06342284 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT06342284 expected to complete?

The registry lists a primary completion date of 31 Mar 2028 and a study completion date of 21 Mar 2031. The sponsor last updated the record on 13 Apr 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.